95: DND - A New Device for Diabetic Neuropathy Testing with Daniel Medrano, CEO of DND episode artwork

EPISODE · Oct 4, 2018 · 10 MIN

95: DND - A New Device for Diabetic Neuropathy Testing with Daniel Medrano, CEO of DND

from Medical Practice Trends

Daniel Medrano, CEO of DND, presents the DND, a hand-held diabetic neuropathy device for in-office evaluation. This issue (10:42): - What is the Diabetic Neuropathy Device? - What objective measurements are provided? - Why its numerical output is superior to the qualitative output of other devices - How does the DND best fit in your practice?    

Episode metadata supplied by the publisher feed · Published Oct 4, 2018

Embed this episode

NOW PLAYING

95: DND - A New Device for Diabetic Neuropathy Testing with Daniel Medrano, CEO of DND

0:00 10:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Practice Trends?

This episode is 10 minutes long.

When was this Medical Practice Trends episode published?

This episode was published on October 4, 2018.

Can I download this Medical Practice Trends episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!